BUY Gland Pharma Limited — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)4 Nov 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·20 May · yesterday
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Gland Pharma
- BUY — Vishnu Kant Upadhyay, Master Capital Services13 Oct 2026 · ~3 months · target ₹3,400 · Active
- BUY — Kunal Parar, Choice Broking8 Oct 2026 · Same day · target ₹3,235 · Expired
- BUY — Prakash Gaba7 Oct 2026 · ~2 weeks · target ₹3,200 · SL hit
- BUY — Nomura India Research7 Oct 2026 · ~1 year · target ₹3,750 · Active
- BUY — Raja Venkatraman7 Oct 2026 · ~3 months · target ₹3,325 · SL hit
More from Motilal Oswal
- BUY Emcure Pharmaceuticals21 Oct 2026 · ~1 year · target ₹2,330 · Active
- BUY Aditya Birla Sun Life AMC21 Oct 2026 · ~1 year · target ₹1,160 · Active
- BUY Mahindra & Mahindra Financial Services21 Oct 2026 · ~1 year · target ₹375 · Active
- BUY Hindalco Industries21 Oct 2026 · ~1 year · target ₹1,170 · Active
- BUY Eternal21 Oct 2026 · ~1 year · target ₹420 · Active

